Khachfe HH, Habib JR, Chahrour MA, Nassour I. Robotic pancreaticoduodenectomy: Where do we stand? Artif Intell Gastrointest Endosc 2021; 2(4): 103-109 [DOI: 10.37126/aige.v2.i4.103]
Corresponding Author of This Article
Hussein H Khachfe, MD, Doctor, Research Fellow, Surgery Department, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15261, United States. khachfehh@upmc.edu
Research Domain of This Article
Surgery
Article-Type of This Article
Opinion Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Artif Intell Gastrointest Endosc. Aug 28, 2021; 2(4): 103-109 Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.103
Robotic pancreaticoduodenectomy: Where do we stand?
Hussein H Khachfe, Joseph R Habib, Mohamad A Chahrour, Ibrahim Nassour
Hussein H Khachfe, Ibrahim Nassour, Surgery Department, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, United States
Joseph R Habib, Surgery Department, Johns Hopkins University, Balitmore, MD 21287, United States
Mohamad A Chahrour, Surgery Department, Henry Ford Health System, Detroit, MI 48202, United States
Author contributions: Khachfe HH conceived the idea for the manuscript; Khachfe HH, Habib JR, Chahrour MA, and Nassour I reviewed the literature and drafted the manuscript; Nassour I critically reviewed the manuscript.
Conflict-of-interest statement: The authors report no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hussein H Khachfe, MD, Doctor, Research Fellow, Surgery Department, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15261, United States. khachfehh@upmc.edu
Received: May 18, 2021 Peer-review started: May 18, 2021 First decision: June 22, 2021 Revised: June 24, 2021 Accepted: August 19, 2021 Article in press: August 19, 2021 Published online: August 28, 2021 Processing time: 110 Days and 23.1 Hours
Abstract
Pancreaticoduodenectomy (PD) is a complex operation accompanied by significant morbidity rates. Due to this complexity, the transition to minimally invasive PD has lagged behind other abdominal surgical operations. The safety, feasibility, favorable post-operative outcomes of robotic PD have been suggested by multiple studies. Compared to open surgery and other minimally invasive techniques such as laparoscopy, robotic PD offers satisfactory outcomes, with a non-inferior risk of adverse events. Trends of robotic PD have been on rise with centers substantially increasing the number the operation performed. Although promising, findings on robotic PD need to be corroborated in prospective trials.
Core Tip: The robotic Whipple procedure is a safe and technically feasible surgical operation. Robotic pancreaticoduodenectomy has shown favorable outcomes and is currently increasing in widespread implementation. Prospective trials are needed before this relatively new approach can be fully adopted as a standard of care in patients with pancreatic neoplasms.
